NYLIM
TBI

New York Life Investment Management’s Trueblue TBI Stock Holding History

New York Life Investment Management’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,552
Closed -$300K – 1518
2023
Q4 		$300K Sell
19,552
-450
-2% -$6.29K ﹤0.01% 1213
2023
Q3 		$293K Sell
20,002
-3,152
-14% -$49.1K ﹤0.01% 1167
2023
Q2 		$410K Sell
23,154
-3,950
-15% -$67K ﹤0.01% 954
2023
Q1 		$482K Buy
27,104
+7,469
+38% +$140K 0.01% 849
2022
Q4 		$384K Buy
19,635
+2,213
+13% +$44.9K ﹤0.01% 1059
2022
Q3 		$332K Buy
17,422
+1,280
+8% +$25.9K ﹤0.01% 1059
2022
Q2 		$289K Buy
+16,142
New +$379K ﹤0.01% 1164

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

New York Life Investment Management's TBI Position: Q1 2024 in Review

New York Life Investment Management sold out of Trueblue (TBI) in Q1 2024, closing a stake of 19,552 shares — an estimated $300K sold.

New York Life Investment Management first reported a position in TBI in Q2 2022 and held it in 7 quarters. The position peaked at $482K in Q1 2023. 137 funds tracked by Wall St. Rank hold TBI as of Q1 2024.

  • New York Life Investment Management reported no remaining Trueblue position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 19,552 Trueblue shares in Q1 2024, an estimated $300K.
  • New York Life Investment Management first reported a position in Trueblue in Q2 2022 and held it in 7 quarters.
  • New York Life Investment Management's Trueblue position peaked at $482K in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Trueblue as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.